Literature DB >> 21298507

The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's disease.

Lakshmi Srinivasan1, Edward R Laws, Robert L Dodd, Monique M Monita, Christyn E Tannenbaum, Kjersti M Kirkeby, Olivia S Chu, Griffith R Harsh, Laurence Katznelson.   

Abstract

Rapid assessment of adrenal function is critical following transsphenoidal surgery (TSS) for Cushing's disease (CD) in order to determine surgical efficacy. We hypothesize that there may be a role for ACTH measurement as a rapid indicator of adrenal function. Following surgery for CD, glucocorticoids were withheld and paired plasma ACTH and serum cortisol levels were measured every 6 h. Post-operative hypocortisolemia was defined as serum cortisol <2 mcg/dl or a serum cortisol <5 mcg/dl with the onset of symptoms of adrenal insufficiency within 72 h. We studied 12 subjects, all female, mean age 44.6 years (range 25-55), including 13 surgeries: nine subjects attained hypocortisolemia. Plasma ACTH levels decreased more in subjects with hypocortisolemia (0.9 pg/ml/hr, P = 0.0028) versus those with persistent disease (0 0.2 pg/ml/hr, P = 0.26) within the first 48 h after surgery. In contrast to subjects with persistent disease, all subjects with hypocortisolemia achieved a plasma ACTH <20 pg/ml by 19 h (range 1-19 h). Four of the nine subjects with hypocortisolemia achieved plasma ACTH <20 pg/ml by 13 h and the remaining five subjects by 19 h. Hypocortisolemia occurred between 3-36 h following achievement of a plasma ACTH <20 pg/ml. In CD, a reduction in postoperative plasma ACTH levels differentiates subjects with surgical remission versus subjects with persistent disease. The utility of plasma ACTH measurements in the postoperative management of CD remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21298507     DOI: 10.1007/s11102-011-0295-2

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  21 in total

1.  Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors.

Authors:  F R Pimentel-Filho; A Cukiert; F Miyashita; M K Huayllas; M Knoepfelmacher; L R Salgado; B Liberman
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

2.  Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease.

Authors:  Alberto M Pereira; Maarten O van Aken; Hans van Dulken; Pieter J Schutte; Nienke R Biermasz; Jan W A Smit; Ferdinand Roelfsema; Johannes A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

Review 3.  Diagnosis and complications of Cushing's syndrome: a consensus statement.

Authors:  G Arnaldi; A Angeli; A B Atkinson; X Bertagna; F Cavagnini; G P Chrousos; G A Fava; J W Findling; R C Gaillard; A B Grossman; B Kola; A Lacroix; T Mancini; F Mantero; J Newell-Price; L K Nieman; N Sonino; M L Vance; A Giustina; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

4.  Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively.

Authors:  F R Pimentel-Filho; M E R Silva; K C Nogueira; K Berger; A Cukiert; B Liberman
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

5.  Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing's disease do not predict cure.

Authors:  K E Graham; M H Samuels; H Raff; S L Barnwell; D M Cook
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

6.  The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.

Authors:  J Flitsch; U J Knappe; D K Lüdecke
Journal:  Zentralbl Neurochir       Date:  2003

Review 7.  Pituitary surgery and postoperative management in Cushing's disease.

Authors:  Andrea L Utz; Brooke Swearingen; Beverly M K Biller
Journal:  Endocrinol Metab Clin North Am       Date:  2005-06       Impact factor: 4.741

8.  Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.

Authors:  Gary D Hammer; J Blake Tyrrell; Kathleen R Lamborn; Carol B Applebury; Elizabeth T Hannegan; Scott Bell; Riva Rahl; Amy Lu; Charles B Wilson
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

9.  Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.

Authors:  Joseph C T Chen; Aitun P Amar; SooHo Choi; Peter Singer; Wnluam T Couldwell; Martin H Weiss
Journal:  J Neurosurg       Date:  2003-05       Impact factor: 5.115

10.  Late recurrences of Cushing's disease after initial successful transsphenoidal surgery.

Authors:  Chirag G Patil; Daniel M Prevedello; Shivanand P Lad; Mary Lee Vance; Michael O Thorner; Laurence Katznelson; Edward R Laws
Journal:  J Clin Endocrinol Metab       Date:  2007-12-04       Impact factor: 5.958

View more
  8 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 2.  Approach to the postoperative patient with Cushing's disease.

Authors:  Martin J Rutkowski; Jonathan D Breshears; Sandeep Kunwar; Manish K Aghi; Lewis S Blevins
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

3.  A Comprehensive Approach to Predicting the Outcomes of Transsphenoidal Endoscopic Adenomectomy in Patients with Cushing's Disease.

Authors:  Natalia V Kuritsyna; Uliana A Tsoy; Vladislav Y Cherebillo; Artem A Paltsev; Anton V Ryzhkov; Pavel A Ryazanov; Vladimir K Ryzhkov; Elena N Grineva
Journal:  J Pers Med       Date:  2022-05-16

4.  Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.

Authors:  Nadia Hameed; Chris G Yedinak; Jessica Brzana; Sakir H Gultekin; Nicholas D Coppa; Aclan Dogan; Johnny B Delashaw; Maria Fleseriu
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

5.  Preoperative Lateralization Modalities for Cushing Disease: Is Dynamic Magnetic Resonance Imaging or Cavernous Sinus Sampling More Predictive of Intraoperative Findings?

Authors:  Hai Sun; Chris Yedinak; Alp Ozpinar; Jim Anderson; Aclan Dogan; Johnny Delashaw; Maria Fleseriu
Journal:  J Neurol Surg B Skull Base       Date:  2015-01-21

6.  The prognostic value of perioperative profiles of ACTH and cortisol for recurrence after transsphenoidal hypophysectomy in dogs with corticotroph adenomas.

Authors:  S J van Rijn; J M Hanson; D Zierikzee; H S Kooistra; L C Penning; M A Tryfonidou; B P Meij
Journal:  J Vet Intern Med       Date:  2015-05-08       Impact factor: 3.333

7.  Prognostic usefulness of ACTH in the postoperative period of Cushing's disease.

Authors:  Pablo Abellán-Galiana; Carmen Fajardo-Montañana; Pedro Riesgo-Suárez; Marcelino Pérez-Bermejo; Celia Ríos-Pérez; José Gómez-Vela
Journal:  Endocr Connect       Date:  2019-09       Impact factor: 3.335

8.  Pituitary Hormones and Orofacial Pain.

Authors:  Gregory Dussor; Jacob T Boyd; Armen N Akopian
Journal:  Front Integr Neurosci       Date:  2018-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.